INSM Insmed Incorporated

NASDAQ
$121.86

Insmed Incorporated (INSM) is expected to report earnings on January 28, 2027, before the market open. The consensus earnings estimate is a loss of $0.39 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.8% since its last earnings release on October 29, 2026.

Insmed Missed Expectations, Lowers Guidance
Thursday, October 29, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 28
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.39)
Rev est $602.26M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $113.03

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Insmed Incorporated

Insmed Inc is a biopharmaceutical company engaged in developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. Its products candidates includes ARIKAYCE.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.